Surmodics, Inc. (SRDX)
SRDX Stock Price Chart
Explore Surmodics, Inc. interactive price chart. Choose custom timeframes to analyze SRDX price movements and trends.
SRDX Company Profile
Discover essential business fundamentals and corporate details for Surmodics, Inc. (SRDX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
4 Mar 1998
Employees
389.00
Website
https://www.surmodics.comCEO
Gary R. Maharaj
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
SRDX Financial Timeline
Browse a chronological timeline of Surmodics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 28 Jan 2026
Upcoming earnings on 5 Nov 2025
EPS estimate is -$0.19, while revenue estimate is $30.14M.
Earnings released on 8 Aug 2025
EPS came in at $0.06 surpassing the estimated -$0.21 by +128.57%, while revenue for the quarter reached $29.57M , missing expectations by -1.37%.
Earnings released on 30 Apr 2025
EPS came in at -$0.13 falling short of the estimated -$0.06 by -116.67%, while revenue for the quarter reached $28.09M , missing expectations by -12.86%.
Earnings released on 30 Jan 2025
EPS came in at -$0.04 surpassing the estimated -$0.12 by +66.67%, while revenue for the quarter reached $29.92M , missing expectations by -10.32%.
Earnings released on 6 Nov 2024
EPS came in at -$0.13 surpassing the estimated -$0.27 by +51.85%, while revenue for the quarter reached $33.23M , beating expectations by +9.34%.
Earnings released on 31 Jul 2024
EPS came in at -$0.27 surpassing the estimated -$0.31 by +12.90%, while revenue for the quarter reached $30.34M , missing expectations by -0.16%.
Earnings released on 1 May 2024
EPS came in at $0.07 surpassing the estimated -$0.36 by +119.44%, while revenue for the quarter reached $31.96M , beating expectations by +10.81%.
Earnings released on 1 Feb 2024
EPS came in at -$0.06 surpassing the estimated -$0.30 by +81.42%, while revenue for the quarter reached $30.55M , beating expectations by +3.08%.
Earnings released on 8 Nov 2023
EPS came in at $0.53 surpassing the estimated $0.19 by +178.95%, while revenue for the quarter reached $27.97M , beating expectations by +6.47%.
Earnings released on 2 Aug 2023
EPS came in at $0.52 surpassing the estimated $0.05 by +940.00%, while revenue for the quarter reached $52.48M , beating expectations by +37.90%.
Earnings released on 26 Apr 2023
EPS came in at -$0.40 surpassing the estimated -$0.49 by +18.37%, while revenue for the quarter reached $27.20M , beating expectations by +5.17%.
Earnings released on 6 Feb 2023
EPS came in at -$0.50 surpassing the estimated -$0.64 by +21.88%, while revenue for the quarter reached $24.93M , beating expectations by +2.92%.
Earnings released on 9 Nov 2022
EPS came in at -$0.26 surpassing the estimated -$0.38 by +31.58%, while revenue for the quarter reached $25.99M , beating expectations by +7.87%.
Earnings released on 27 Jul 2022
EPS came in at -$0.34 surpassing the estimated -$0.39 by +12.82%, while revenue for the quarter reached $24.85M , missing expectations by -1.35%.
Earnings released on 27 Apr 2022
EPS came in at -$0.22 surpassing the estimated -$0.32 by +31.25%, while revenue for the quarter reached $26.11M , beating expectations by +8.89%.
Earnings released on 3 Feb 2022
EPS came in at -$0.13 surpassing the estimated -$0.36 by +63.89%, while revenue for the quarter reached $23.00M , missing expectations by -2.97%.
Earnings released on 10 Nov 2021
EPS came in at -$0.10 surpassing the estimated -$0.25 by +60.00%, while revenue for the quarter reached $23.97M , missing expectations by -30.56%.
Earnings released on 4 Aug 2021
EPS came in at -$0.17 falling short of the estimated -$0.11 by -54.55%, while revenue for the quarter reached $23.87M , beating expectations by +2.42%.
Earnings released on 28 Apr 2021
EPS came in at $0.62 falling short of the estimated $0.63 by -1.59%, while revenue for the quarter reached $35.00M , missing expectations by -1.56%.
Earnings released on 9 Feb 2021
EPS came in at $0.02 surpassing the estimated -$0.06 by +133.33%, while revenue for the quarter reached $22.30M , missing expectations by -50.00%.
Earnings released on 4 Nov 2020
EPS came in at -$0.18 falling short of the estimated -$0.08 by -125.00%, while revenue for the quarter reached $22.54M , beating expectations by +7.74%.
SRDX Stock Performance
Access detailed SRDX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.